Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000158

President and CEO sold 4,746 shares at $2.96 ($14,065)

  • President and CEO acquired 10,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2021-12-01 Option exercise +10,938 289,697 D: show line 1 in the form
Brunn Carsten President and CEO 2021-12-02 Sale −4,746 $2.96 $14,065 284,951 D: show line 2 in the form
Open-market sales · 4,746 sh · avg $2.96 · $14,065

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Brunn Carsten President and CEO 2021-12-01 Option exercise · Restricted Stock Units −10,938 43,750 D: show line 3 in the form
Loading xslF345X03/wf-form4_163856690437223.xml…